Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

NCT00006495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: ALVAC(2)120(B,MN)GNP (vCP1452)
BIOLOGICAL: HIV-1 Immunogen

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)